Suppr超能文献

关于用中医药治疗新型冠状病毒肺炎的思考

Reflections on treatment of COVID-19 with traditional Chinese medicine.

作者信息

Luo Hua, Gao Yan, Zou Jian, Zhang Siyuan, Chen Hanbin, Liu Qiao, Tan Dechao, Han Yan, Zhao Yonghua, Wang Shengpeng

机构信息

Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macao SAR, China.

出版信息

Chin Med. 2020 Sep 3;15:94. doi: 10.1186/s13020-020-00375-1. eCollection 2020.

Abstract

Coronavirus disease 2019 (COVID-19) pandemic is spreading rapidly around the globe. By the establishment of an integrative system combining both traditional Chinese medicine (TCM) and western medicine, China has achieved good clinical efficacy in the prevention and control of the pandemic. The advantages of TCM in the treatment of COVID-19 include effective relief of symptoms, retarding the development from mild and moderate to severe, improvement of cure rate, reducing death rates, and promotion of rehabilitation. Besides, according to the different severity levels of individual cases, the National Health Commission of the People's Republic of China issued treatment guidelines that provide corresponding prescriptions for patients. From the perspective of TCM, this review aims to analyze the role of a variety of TCM prescriptions in the treatment of COVID-19, focusing on the analysis of the "Three TCM prescriptions and three medicines" recommended by the Chinese authorities during the pandemic. We expect that this review will provide insights into the prevention and treatment of COVID-19 with TCM.

摘要

2019冠状病毒病(COVID-19)大流行正在全球迅速蔓延。通过建立中西医结合的综合体系,中国在疫情防控方面取得了良好的临床疗效。中医药在治疗COVID-19方面的优势包括有效缓解症状、延缓轻症和中症向重症发展、提高治愈率、降低死亡率以及促进康复。此外,根据个体病例的不同严重程度,中华人民共和国国家卫生健康委员会发布了治疗指南,为患者提供相应的方剂。从中医角度出发,本综述旨在分析各类中药方剂在治疗COVID-19中的作用,重点分析疫情期间中国官方推荐的“三方三药”。我们期望本综述能为中医药防治COVID-19提供见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c0/7469401/dc6f92509e42/13020_2020_375_Fig1_HTML.jpg

相似文献

1
Reflections on treatment of COVID-19 with traditional Chinese medicine.
Chin Med. 2020 Sep 3;15:94. doi: 10.1186/s13020-020-00375-1. eCollection 2020.
2
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501.
3
Analysis on oral medication rules of traditional Chinese medicine prescriptions for prevention of COVID-19.
Chin Herb Med. 2021 Oct;13(4):502-517. doi: 10.1016/j.chmed.2021.10.007. Epub 2021 Oct 12.
4
Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19.
Curr Med Chem. 2024;31(21):3118-3131. doi: 10.2174/0929867330666230331084126.
5
Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.
Front Med. 2020 Dec;14(6):760-775. doi: 10.1007/s11684-020-0803-8. Epub 2020 Sep 14.
7
Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19.
Eur J Integr Med. 2020 Jun;36:101116. doi: 10.1016/j.eujim.2020.101116. Epub 2020 Apr 3.
10
Traditional Chinese medicine treatment for COVID-19: An overview of systematic reviews and meta-analyses.
J Integr Med. 2022 Sep;20(5):416-426. doi: 10.1016/j.joim.2022.06.006. Epub 2022 Jun 24.

引用本文的文献

1
Natural products alleviate viral pneumonia by modulating inflammatory and oxidative-stress pathways.
Front Pharmacol. 2025 Aug 11;16:1657829. doi: 10.3389/fphar.2025.1657829. eCollection 2025.
3
Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature.
J Tradit Complement Med. 2024 Jun 22;15(2):107-118. doi: 10.1016/j.jtcme.2024.06.010. eCollection 2025 Mar.
4
Interferon Point Alteration in Hospitalized Patients with and Without COVID-19.
Med Acupunct. 2024 Dec 17;36(6):343-349. doi: 10.1089/acu.2023.0095. eCollection 2024 Dec.
5
Ayurvedic and Chinese Herbs against Coronaviruses.
Curr Pharm Des. 2024;30(21):1681-1698. doi: 10.2174/0113816128269864231112094917.
6
CPMI-ChatGLM: parameter-efficient fine-tuning ChatGLM with Chinese patent medicine instructions.
Sci Rep. 2024 Mar 16;14(1):6403. doi: 10.1038/s41598-024-56874-w.

本文引用的文献

2
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza.
Clin Infect Dis. 2020 Dec 17;71(10):2669-2678. doi: 10.1093/cid/ciaa709.
3
Probiotics and COVID-19: is there any link?
Lett Appl Microbiol. 2020 Sep;71(3):229-234. doi: 10.1111/lam.13334. Epub 2020 Jul 16.
4
The potential insights of Traditional Chinese Medicine on treatment of COVID-19.
Chin Med. 2020 May 24;15:51. doi: 10.1186/s13020-020-00326-w. eCollection 2020.
5
Gut microbiota and Covid-19- possible link and implications.
Virus Res. 2020 Aug;285:198018. doi: 10.1016/j.virusres.2020.198018. Epub 2020 May 13.
6
[Research progress in molecular pharmacognosy of Pogostemon cablin].
Zhongguo Zhong Yao Za Zhi. 2019 Nov;44(22):4781-4785. doi: 10.19540/j.cnki.cjcmm.20190729.105.
7
[Effect and mechanism of Mahuang Tang against influenza A/H1N1 virus ].
Zhongguo Zhong Yao Za Zhi. 2018 Feb;43(3):563-570. doi: 10.19540/j.cnki.cjcmm.20171113.010.
8
Seeing the unseen of Chinese herbal medicine processing (): advances in new perspectives.
Chin Med. 2018 Jan 17;13:4. doi: 10.1186/s13020-018-0163-3. eCollection 2018.
9
Antitussive and expectorant activities of licorice and its major compounds.
Bioorg Med Chem. 2018 Jan 1;26(1):278-284. doi: 10.1016/j.bmc.2017.11.046. Epub 2017 Dec 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验